Error: Could not add to watchlist. X

Alnylam Pharmaceuticals Inc

+ Watchlist
ALNY:US
NASDAQ GS
127.43
USD
1.97
1.57%
As of 20:10:00 ET on 08/01/2015.
Open
126.55
Day Range
124.82 - 130.00
Volume
414,275
Previous Close
125.46
52Wk Range
52.35 - 140.00
1 Yr Return
137.26%
Open
126.55
Day Range
124.82 - 130.00
Volume
414,275
Previous Close
125.46
52Wk Range
52.35 - 140.00
1 Yr Return
137.26%
YTD Return
31.37%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.11
Market Cap (b USD)
10.740
Shares Outstanding (m)
84.283
Price/Sales (TTM)
163.84
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
ADDRESS
300 Third Steet
Cambridge, MA 02142
United States
PHONE
1-617-551-8200
  • John M Maraganore
    Chief Executive Officer
  • Barry E Greene
    President/COO
  • David-Alexandre Gros
    Senior VP/Chief Business Ofcr
  • Akshay K Vaishnaw
    Exec VP:Research & Dev
  • Laurie Bartlett Keating
    Senior VP/Secretary/Gen Cnsl
Show More